[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368994-105":59,"doc-detail-368994-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","revisiting-the-role-of-metabolic-reprogramming-as-a-contributor-to-prostate-cancer-disease-progression","Revisiting the role of metabolic reprogramming as a contributor to prostate cancer disease progression","","Prostate cancer (PCa) is a leading malignancy worldwide, and metabolic reprogramming is central to tumor progression and therapeutic resistance. During advancement to castration-resistant prostate cancer, major metabolic pathway shifts occur, including glycolysis, amino-acid utilization, and lipid acid metabolism, supporting survival in altered tumor microenvironments. Glutamine metabolism drives energy and carbon supply, macromolecule synthesis, and resistance. Pioneer transcription factors, including the androgen receptor, connect metabolic regulation with signaling metabolites. This review summarizes stage-specific metabolic features and highlights therapeutic strategies targeting metabolic vulnerabilities to improve treatment outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/revisiting-the-role-of-metabolic-reprogramming-as-a-contributor-to-prostate-cancer-disease-progression/368994/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/revisiting-the-role-of-metabolic-reprogramming-as-a-contributor-to-prostate-cancer-disease-progression/368994.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is metabolic reprogramming important in prostate cancer progression?","Question",{"text":112,"@type":113},"Metabolic reprogramming increases energy and biomass requirements for rapid proliferation and contributes to treatment resistance as PCa advances.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What metabolic changes occur in castration-resistant prostate cancer (CRPC)?",{"text":117,"@type":113},"CRPC is associated with significant alterations in metabolic pathways, including glycolysis, amino acid utilization, and lipid acid metabolism.",{"name":119,"@type":110,"acceptedAnswer":120},"How does glutamine metabolism contribute to advanced prostate cancer?",{"text":121,"@type":113},"Glutamine metabolism supplies energy and carbon skeletons for the tricarboxylic acid cycle, supports synthesis of nucleotides and lipids, and acts as a key driver of therapeutic resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368994,1790510116,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review Article  \nRevisiting the role of metabolic reprogramming as a contributor to prostate cancer disease progression  \nHekang Ding1,2,3, Qingwei Meng1,2,3, Jun Zhou1,2,3, Li Chen4, Jiaoti Huang5,6, Bing Zhao4, Lingfan Xu1,2,3  \n1Department of Urology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, China;  \n2Institute of Urology, Anhui Medical University, Hefei, Anhui 230001, China;  \n3Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui 230001, China;  \n4Department of Geriatrics, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China; 5Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA;  \n6Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA.  \nAbstract  \nProstate cancer (PCa) is one of the most common malignancies worldwide, and metabolic reprogramming plays a crucial role, particularly in tumor progression and therapeutic resistance. As PCa progresses into advanced stages, such as castration-resistant prostate cancer, significant alterations in tumor metabolic pathways, including glycolysis, amino acid utilization, and lipid acid metabolism, occur. These reprogrammed metabolic pathways support the survival and proliferation of tumor cells in altered tumor microenvironments. Glutamine metabolism is significant in advanced PCa because this pathway not only contributes to the tricarboxylic acid cycle by providing energy and carbon skeletons but also supports the synthesis of macromolecules such as nucleotides and lipids and acts as a key driver of therapeutic resistance. In addition, pioneer transcription factors, such as the androgen receptor, either regulate the activity of metabolic pathways or are influenced by specific signaling metabolites. Targeting metabolic vulnerability is an ideal therapeutic strategy for advanced PCa. The aim of this review was to describe distinct metabolic features in different stages of PCa and highlight how to improve therapeutic effects by targeting tumor metabolism.  \nKeywords: Metabolic reprogramming; Glutamine metabolism; Prostate cancer; Targeted therapy; Castration-resistant prostate cancer  \nIntroduction  \nProstate cancer (PCa) is the most common urological cancer, with an estimated 300,000 new cases diagnosed annually in the United States. [1] Morbidity is also high in Eastern countries, including China. The overall mortality rate of PCa is approximately 4. 8% . [2]  \nMost PCa patients are initially diagnosed with localized disease. These early-stage, low-grade cases, in which the disease has not spread beyond the prostate, are often cured through active surveillance, surgery, or radiotherapy, with a 10-year survival rate exceeding 90% . For recurrent, advanced, and metastatic PCa, androgen deprivation therapy (ADT), which inhibits androgen production or blocks androgen receptor (AR) function, is the goldstandard treatment. [3,4] While ADT significantly delays disease progression, nearly all patients eventually develop castration resistance, which is termed castration-resistant prostate cancer (CRPC) . [5]  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000003844 |\n\nBecause second-generation antiandrogen drugs have a limited duration of efficacy in treating CRPC, innovative therapeutic strategies are needed. Understanding the molecular basis of disease progression and exploring treatment strategies beyond AR inhibition are crucial to prevent disease progression or effectively treat CRPC.  \nCellular energy dysregulation is a hallmark of cancer. Metabolic reprogramming increases the energy and biomass taken in by tumor cells to satisfy the cells’ requirements for rapid cellular proliferation and treatment resistance. [6] Research on t","cbCaihJPk6Kkr91r","https://ap.wps.com/l/cbCaihJPk6Kkr91r","pdf",833766,11,"English","# Abstract\n# Introduction\n# Glucose Metabolism","[{\"question\":\"Why is metabolic reprogramming important in prostate cancer progression?\",\"answer\":\"Metabolic reprogramming increases energy and biomass requirements for rapid proliferation and contributes to treatment resistance as PCa advances.\"},{\"question\":\"What metabolic changes occur in castration-resistant prostate cancer (CRPC)?\",\"answer\":\"CRPC is associated with significant alterations in metabolic pathways, including glycolysis, amino acid utilization, and lipid acid metabolism.\"},{\"question\":\"How does glutamine metabolism contribute to advanced prostate cancer?\",\"answer\":\"Glutamine metabolism supplies energy and carbon skeletons for the tricarboxylic acid cycle, supports synthesis of nucleotides and lipids, and acts as a key driver of therapeutic resistance.\"}]","Revisiting the role of metabolic reprogramming as a contributor to prostate cancer disease progression | PDF",1790180082,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f499942f78837b55902c412dedfb07d7.webp",983,1324,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d48338db26f756c9482b2624799232b.webp",982,1323,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e867a8c88655c8341c3b98129a14f646.webp",981,1321,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a5f35161895996aa95b6b11b3df6275.webp",980,1320]